カテゴリー： Market Monitor Global, 世界, 医療/バイオ

遺伝子治療におけるアデノ随伴ウイルスベクターの世界市場見通し2023年-2029年

◆英語タイトル：Adeno-Associated Virus Vectors in Gene Therapy Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU4946）

◆商品コード：MMG23JU4946
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：76
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Adeno-Associated Virus Vectors in Gene Therapy Market 調査レポートは次の情報を含め、グローバルにおけるの遺伝子治療におけるアデノ随伴ウイルスベクター市場規模と予測を収録しています。・世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：売上、2018年-2023年、2024年-2029年
・世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「血清型2（AVV2）」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

遺伝子治療におけるアデノ随伴ウイルスベクターのグローバル主要企業は、Amicus Therapeutics、 Asklepios Biopharmaceutical、 BioMarin Pharmaceutical、 Coave Therapeutics、 MeiraGTx、 Neurocrine Biosciences、 Pfizer、 Roche Holding、 Sangamo Therapeutics、 Sarepta Therapeutics、 Spark Therapeutics、 Voyager Therapeutics、 NightstaRxなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、遺伝子治療におけるアデノ随伴ウイルスベクターのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：タイプ別、2018年-2023年、2024年-2029年
世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：タイプ別市場シェア、2022年
・血清型2（AVV2）、合成血清型、その他

世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：用途別、2018年-2023年、2024年-2029年
世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：用途別市場シェア、2022年
・アルツハイマー病、嚢胞性線維症、血友病B、パーキンソン病

世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：地域・国別、2018年-2023年、2024年-2029年
世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における遺伝子治療におけるアデノ随伴ウイルスベクターのグローバル売上、2018年-2023年
・主要企業における遺伝子治療におけるアデノ随伴ウイルスベクターのグローバル売上シェア、2022年
・主要企業における遺伝子治療におけるアデノ随伴ウイルスベクターのグローバル販売量、2018年-2023年
・主要企業における遺伝子治療におけるアデノ随伴ウイルスベクターのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Amicus Therapeutics、 Asklepios Biopharmaceutical、 BioMarin Pharmaceutical、 Coave Therapeutics、 MeiraGTx、 Neurocrine Biosciences、 Pfizer、 Roche Holding、 Sangamo Therapeutics、 Sarepta Therapeutics、 Spark Therapeutics、 Voyager Therapeutics、 NightstaRx

*************************************************************

・調査・分析レポートの概要
遺伝子治療におけるアデノ随伴ウイルスベクター市場の定義
市場セグメント
世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場規模
世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場規模：2022年 VS 2029年
世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの遺伝子治療におけるアデノ随伴ウイルスベクターの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の遺伝子治療におけるアデノ随伴ウイルスベクター製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：血清型2（AVV2）、合成血清型、その他
遺伝子治療におけるアデノ随伴ウイルスベクターのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：アルツハイマー病、嚢胞性線維症、血友病B、パーキンソン病
遺伝子治療におけるアデノ随伴ウイルスベクターの用途別グローバル売上・予測

・地域別市場分析
地域別遺伝子治療におけるアデノ随伴ウイルスベクター市場規模 2022年と2029年
地域別遺伝子治療におけるアデノ随伴ウイルスベクター売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Amicus Therapeutics、 Asklepios Biopharmaceutical、 BioMarin Pharmaceutical、 Coave Therapeutics、 MeiraGTx、 Neurocrine Biosciences、 Pfizer、 Roche Holding、 Sangamo Therapeutics、 Sarepta Therapeutics、 Spark Therapeutics、 Voyager Therapeutics、 NightstaRx
...

Adeno-associated viruses (AAV) are small viruses that infect humans and some other primate species. They belong to the genus Dependoparvovirus, which in turn belongs to the family Parvoviridae. They are small (20 nm) replication-defective, nonenveloped viruses and have linear single-stranded DNA (ssDNA) genome of approximately 4.8 kilobases (kb).
This report aims to provide a comprehensive presentation of the global market for Adeno-Associated Virus Vectors in Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adeno-Associated Virus Vectors in Gene Therapy. This report contains market size and forecasts of Adeno-Associated Virus Vectors in Gene Therapy in global, including the following market information:
Global Adeno-Associated Virus Vectors in Gene Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Adeno-Associated Virus Vectors in Gene Therapy Market Sales, 2018-2023, 2024-2029, (Kg)
Global top five Adeno-Associated Virus Vectors in Gene Therapy companies in 2022 (%)
The global Adeno-Associated Virus Vectors in Gene Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Serotype 2 (AVV 2) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Adeno-Associated Virus Vectors in Gene Therapy include Amicus Therapeutics, Asklepios Biopharmaceutical, BioMarin Pharmaceutical, Coave Therapeutics, MeiraGTx, Neurocrine Biosciences, Pfizer, Roche Holding and Sangamo Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Adeno-Associated Virus Vectors in Gene Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adeno-Associated Virus Vectors in Gene Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Adeno-Associated Virus Vectors in Gene Therapy Market Segment Percentages, by Type, 2022 (%)
Serotype 2 (AVV 2)
Synthetic Serotypes
Others
Global Adeno-Associated Virus Vectors in Gene Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Adeno-Associated Virus Vectors in Gene Therapy Market Segment Percentages, by Application, 2022 (%)
Alzheimer’s Disease
Cystic Dibrosis
Hemophilia B
Parkinson’s Disease
Global Adeno-Associated Virus Vectors in Gene Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Adeno-Associated Virus Vectors in Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adeno-Associated Virus Vectors in Gene Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Adeno-Associated Virus Vectors in Gene Therapy revenues share in global market, 2022 (%)
Key companies Adeno-Associated Virus Vectors in Gene Therapy sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Adeno-Associated Virus Vectors in Gene Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amicus Therapeutics
Asklepios Biopharmaceutical
BioMarin Pharmaceutical
Coave Therapeutics
MeiraGTx
Neurocrine Biosciences
Pfizer
Roche Holding
Sangamo Therapeutics
Sarepta Therapeutics
Spark Therapeutics
Voyager Therapeutics
NightstaRx
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adeno-Associated Virus Vectors in Gene Therapy, market overview.
Chapter 2: Global Adeno-Associated Virus Vectors in Gene Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Adeno-Associated Virus Vectors in Gene Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adeno-Associated Virus Vectors in Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Adeno-Associated Virus Vectors in Gene Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Adeno-Associated Virus Vectors in Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adeno-Associated Virus Vectors in Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adeno-Associated Virus Vectors in Gene Therapy Overall Market Size
2.1 Global Adeno-Associated Virus Vectors in Gene Therapy Market Size: 2022 VS 2029
2.2 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Adeno-Associated Virus Vectors in Gene Therapy Sales: 2018-2029
3 Company Landscape
3.1 Top Adeno-Associated Virus Vectors in Gene Therapy Players in Global Market
3.2 Top Global Adeno-Associated Virus Vectors in Gene Therapy Companies Ranked by Revenue
3.3 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Companies
3.4 Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Companies
3.5 Global Adeno-Associated Virus Vectors in Gene Therapy Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Adeno-Associated Virus Vectors in Gene Therapy Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Adeno-Associated Virus Vectors in Gene Therapy Players in Global Market
3.8.1 List of Global Tier 1 Adeno-Associated Virus Vectors in Gene Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Adeno-Associated Virus Vectors in Gene Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Market Size Markets, 2022 & 2029
4.1.2 Serotype 2 (AVV 2)
4.1.3 Synthetic Serotypes
4.1.4 Others
4.2 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue & Forecasts
4.2.1 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2023
4.2.2 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2024-2029
4.2.3 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
4.3 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Sales & Forecasts
4.3.1 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2023
4.3.2 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2024-2029
4.3.3 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
4.4 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2022 & 2029
5.1.2 Alzheimer’s Disease
5.1.3 Cystic Dibrosis
5.1.4 Hemophilia B
5.1.5 Parkinson’s Disease
5.2 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue & Forecasts
5.2.1 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2023
5.2.2 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2024-2029
5.2.3 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
5.3 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Sales & Forecasts
5.3.1 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2023
5.3.2 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2024-2029
5.3.3 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
5.4 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2022 & 2029
6.2 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue & Forecasts
6.2.1 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2023
6.2.2 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2024-2029
6.2.3 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
6.3 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Sales & Forecasts
6.3.1 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2023
6.3.2 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2024-2029
6.3.3 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2029
6.4.2 By Country – North America Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2029
6.4.3 US Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.4.4 Canada Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.4.5 Mexico Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2029
6.5.2 By Country – Europe Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2029
6.5.3 Germany Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5.4 France Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5.5 U.K. Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5.6 Italy Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5.7 Russia Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5.8 Nordic Countries Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5.9 Benelux Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2029
6.6.2 By Region – Asia Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2029
6.6.3 China Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.6.4 Japan Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.6.5 South Korea Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.6.6 Southeast Asia Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.6.7 India Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2029
6.7.2 By Country – South America Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2029
6.7.3 Brazil Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.7.4 Argentina Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2029
6.8.3 Turkey Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.8.4 Israel Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.8.5 Saudi Arabia Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.8.6 UAE Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amicus Therapeutics
7.1.1 Amicus Therapeutics Company Summary
7.1.2 Amicus Therapeutics Business Overview
7.1.3 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.1.4 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.1.5 Amicus Therapeutics Key News & Latest Developments
7.2 Asklepios Biopharmaceutical
7.2.1 Asklepios Biopharmaceutical Company Summary
7.2.2 Asklepios Biopharmaceutical Business Overview
7.2.3 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.2.4 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.2.5 Asklepios Biopharmaceutical Key News & Latest Developments
7.3 BioMarin Pharmaceutical
7.3.1 BioMarin Pharmaceutical Company Summary
7.3.2 BioMarin Pharmaceutical Business Overview
7.3.3 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.3.4 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.3.5 BioMarin Pharmaceutical Key News & Latest Developments
7.4 Coave Therapeutics
7.4.1 Coave Therapeutics Company Summary
7.4.2 Coave Therapeutics Business Overview
7.4.3 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.4.4 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.4.5 Coave Therapeutics Key News & Latest Developments
7.5 MeiraGTx
7.5.1 MeiraGTx Company Summary
7.5.2 MeiraGTx Business Overview
7.5.3 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.5.4 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.5.5 MeiraGTx Key News & Latest Developments
7.6 Neurocrine Biosciences
7.6.1 Neurocrine Biosciences Company Summary
7.6.2 Neurocrine Biosciences Business Overview
7.6.3 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.6.4 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.6.5 Neurocrine Biosciences Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.7.4 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Roche Holding
7.8.1 Roche Holding Company Summary
7.8.2 Roche Holding Business Overview
7.8.3 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.8.4 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.8.5 Roche Holding Key News & Latest Developments
7.9 Sangamo Therapeutics
7.9.1 Sangamo Therapeutics Company Summary
7.9.2 Sangamo Therapeutics Business Overview
7.9.3 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.9.4 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.9.5 Sangamo Therapeutics Key News & Latest Developments
7.10 Sarepta Therapeutics
7.10.1 Sarepta Therapeutics Company Summary
7.10.2 Sarepta Therapeutics Business Overview
7.10.3 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.10.4 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.10.5 Sarepta Therapeutics Key News & Latest Developments
7.11 Spark Therapeutics
7.11.1 Spark Therapeutics Company Summary
7.11.2 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Business Overview
7.11.3 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.11.4 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.11.5 Spark Therapeutics Key News & Latest Developments
7.12 Voyager Therapeutics
7.12.1 Voyager Therapeutics Company Summary
7.12.2 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Business Overview
7.12.3 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.12.4 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.12.5 Voyager Therapeutics Key News & Latest Developments
7.13 NightstaRx
7.13.1 NightstaRx Company Summary
7.13.2 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Business Overview
7.13.3 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.13.4 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.13.5 NightstaRx Key News & Latest Developments
8 Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity, Analysis
8.1 Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity, 2018-2029
8.2 Adeno-Associated Virus Vectors in Gene Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Adeno-Associated Virus Vectors in Gene Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Adeno-Associated Virus Vectors in Gene Therapy Supply Chain Analysis
10.1 Adeno-Associated Virus Vectors in Gene Therapy Industry Value Chain
10.2 Adeno-Associated Virus Vectors in Gene Therapy Upstream Market
10.3 Adeno-Associated Virus Vectors in Gene Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Adeno-Associated Virus Vectors in Gene Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Adeno-Associated Virus Vectors in Gene Therapy in Global Market
Table 2. Top Adeno-Associated Virus Vectors in Gene Therapy Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Share by Companies, 2018-2023
Table 5. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Companies, (Kg), 2018-2023
Table 6. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Price (2018-2023) & (US$/Kg)
Table 8. Global Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Product Type
Table 9. List of Global Tier 1 Adeno-Associated Virus Vectors in Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adeno-Associated Virus Vectors in Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), 2018-2023
Table 15. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), 2024-2029
Table 16. By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), 2018-2023
Table 20. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), 2024-2029
Table 21. By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), 2018-2023
Table 25. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), 2024-2029
Table 26. By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2018-2023
Table 29. By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2024-2029
Table 30. By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2018-2023
Table 33. By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2024-2029
Table 34. By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2018-2023
Table 37. By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2024-2029
Table 38. By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2018-2023
Table 41. By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2024-2029
Table 42. By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2018-2023
Table 45. By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2024-2029
Table 46. Amicus Therapeutics Company Summary
Table 47. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 48. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 49. Amicus Therapeutics Key News & Latest Developments
Table 50. Asklepios Biopharmaceutical Company Summary
Table 51. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 52. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 53. Asklepios Biopharmaceutical Key News & Latest Developments
Table 54. BioMarin Pharmaceutical Company Summary
Table 55. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 56. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 57. BioMarin Pharmaceutical Key News & Latest Developments
Table 58. Coave Therapeutics Company Summary
Table 59. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 60. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 61. Coave Therapeutics Key News & Latest Developments
Table 62. MeiraGTx Company Summary
Table 63. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 64. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 65. MeiraGTx Key News & Latest Developments
Table 66. Neurocrine Biosciences Company Summary
Table 67. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 68. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 69. Neurocrine Biosciences Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 72. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 73. Pfizer Key News & Latest Developments
Table 74. Roche Holding Company Summary
Table 75. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 76. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 77. Roche Holding Key News & Latest Developments
Table 78. Sangamo Therapeutics Company Summary
Table 79. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 80. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 81. Sangamo Therapeutics Key News & Latest Developments
Table 82. Sarepta Therapeutics Company Summary
Table 83. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 84. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 85. Sarepta Therapeutics Key News & Latest Developments
Table 86. Spark Therapeutics Company Summary
Table 87. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 88. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 89. Spark Therapeutics Key News & Latest Developments
Table 90. Voyager Therapeutics Company Summary
Table 91. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 92. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 93. Voyager Therapeutics Key News & Latest Developments
Table 94. NightstaRx Company Summary
Table 95. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 96. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 97. NightstaRx Key News & Latest Developments
Table 98. Adeno-Associated Virus Vectors in Gene Therapy Production Capacity (Kg) of Key Manufacturers in Global Market, 2021-2023 (Kg)
Table 99. Global Adeno-Associated Virus Vectors in Gene Therapy Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Adeno-Associated Virus Vectors in Gene Therapy Production by Region, 2018-2023 (Kg)
Table 101. Global Adeno-Associated Virus Vectors in Gene Therapy Production by Region, 2024-2029 (Kg)
Table 102. Adeno-Associated Virus Vectors in Gene Therapy Market Opportunities & Trends in Global Market
Table 103. Adeno-Associated Virus Vectors in Gene Therapy Market Drivers in Global Market
Table 104. Adeno-Associated Virus Vectors in Gene Therapy Market Restraints in Global Market
Table 105. Adeno-Associated Virus Vectors in Gene Therapy Raw Materials
Table 106. Adeno-Associated Virus Vectors in Gene Therapy Raw Materials Suppliers in Global Market
Table 107. Typical Adeno-Associated Virus Vectors in Gene Therapy Downstream
Table 108. Adeno-Associated Virus Vectors in Gene Therapy Downstream Clients in Global Market
Table 109. Adeno-Associated Virus Vectors in Gene Therapy Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Adeno-Associated Virus Vectors in Gene Therapy Segment by Type in 2022
Figure 2. Adeno-Associated Virus Vectors in Gene Therapy Segment by Application in 2022
Figure 3. Global Adeno-Associated Virus Vectors in Gene Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Adeno-Associated Virus Vectors in Gene Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. Adeno-Associated Virus Vectors in Gene Therapy Sales in Global Market: 2018-2029 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Adeno-Associated Virus Vectors in Gene Therapy Revenue in 2022
Figure 9. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
Figure 11. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
Figure 12. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Price (US$/Kg), 2018-2029
Figure 13. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
Figure 15. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
Figure 16. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Price (US$/Kg), 2018-2029
Figure 17. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
Figure 20. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
Figure 21. By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
Figure 22. By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
Figure 23. US Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
Figure 28. Germany Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. France Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
Figure 37. China Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. India Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
Figure 43. By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
Figure 44. Brazil Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
Figure 48. Turkey Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 52. Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity (Kg), 2018-2029
Figure 53. The Percentage of Production Adeno-Associated Virus Vectors in Gene Therapy by Region, 2022 VS 2029
Figure 54. Adeno-Associated Virus Vectors in Gene Therapy Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 遺伝子治療におけるアデノ随伴ウイルスベクターの世界市場見通し2023年-2029年(Adeno-Associated Virus Vectors in Gene Therapy Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

遺伝子治療におけるアデノ随伴ウイルスベクターの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp